Clinical Trial Update: Study to Assess the Blood Concentrations and Actions of Recombinant Human Parathyroid Hormone (rhPTH [1-84]) When Given Once and Twice Daily to Participants With Hypoparathyroidism [Phase 1]

View source ↗

Summary

Phase 1 study assessing blood concentrations and actions of recombinant human parathyroid hormone (rhPTH 1-84) given once vs twice daily in adults with hypopara…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoparathyroidism

Drugs mentioned

• rhPTH(1-84) (recombinant human parathyroid hormone 1-84)

Snippet

Sponsor: Shire | Conditions: Hypoparathyroidism | Phase 1 | Status: COMPLETED | Results posted: 2020-04-09